Methotrexate and epirubicin conjugates as potential antitumor drugs

Methotrexate and epirubicin conjugates as potential antitumor drugs

Introduction: The use of hybrid molecules has become one of the most significant approaches in new cytotoxic drug design. This study describes synthesis and characterization of conjugates consisting of two well-known and characterized chemotherapeutic agents: methotrexate (MTX) and epirubicin (EPR)....

Full description

Bibliographic Details
Main Authors: Szymon Wojciech Kmiecik, Mateusz Adam Krzyścik, Beata Filip-Psurska, Joanna Wietrzyk, Janusz Boratyński, Tomasz Marek Goszczyński
Format: Article
Language:English
Published: Index Copernicus International S.A. 2017-07-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
Methotrexate
Epirubicin
Combinatory therapy
targeted therapy
Bioconjugates
Online Access:http://phmd.pl/gicid/01.3001.0010.3842

Similar Items

Similar Items